Comparison of new point-of-care troponin assay with high sensitivity troponin in diagnosing myocardial infarction
MetadataShow full item record
Objectives: The aim of this study is to compare a new improved point of care cardiac troponin assay (new POC-cTnI) with 1. its predecessor (old POC-cTnI) and 2. a high sensitivity assay (hs-cTnI) for the diagnosis of acute myocardial infarction (AMI) and for major adverse cardiac events (MACE) by 30 days. Methods: This is a single centre observational study, set in Christchurch Hospital, New Zealand. Patients presenting to the emergency department with non-traumatic chest pain underwent blood sampling at 0 h and 2 h post presentation for analysis with the 3 cTnI assays for the outcome of AMI and for analysis using an accelerated diagnostic protocol (ADP-normal 2 h troponins, normal electrocardiograms and Thrombolysis In Myocardial Infarction (TIMI) score of 0 or ≤ 1) for 30 day MACE. Results: Of 962 patients, 220 (22.9%) had AMI. Old POC-cTnI was least sensitive at 70.0% (65.4–73.9%) by 2 h (p < 0.001). New POC-cTnI, sensitivity 93.6% (89.9–96.2%) had similar sensitivity to hs-cTnI, sensitivity 95.0% (91.5–97.3%) (p = 0.508). There were 231 (24.0%) patients with 30 day MACE. When used as part of the ADP, all assays had 100% (98.0–100%) sensitivity using TIMI = 0. Sensitivities of new POC-cTnI ADP, 98.3% (95.4–99.4%), old POC-cTnI, 96.5% (93.2–98.4%) and hs-cTnI, 98.7% (96.0–99.7%) were similar (p = 0.063–0.375) using TIMI ≤ 1. Conclusions: A new POC-cTnI has improved sensitivity for AMI and MACE compared with its predecessor and comparable sensitivity to a high sensitivity assay. Now that sensitivities of the POC assay are improved, the new assay may be a useful alternative to central laboratory assays when rapid turn-around times are not possible.
Showing items related by title, author, creator and subject.
Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndromeCullen, L.; Mueller, C.; Parsonage, W.; Wildi, K.; Greenslade, J.; Twerenbold, R.; Aldous, S.; Meller, B.; Tate, J.; Reichlin, T.; Hammett, C.; Zellweger, C.; Ungerer, J.; Rubini Gimenez, M.; Troughton, R.; Murray, K.; Brown, A.; Mueller, M.; George, P.; Mosimann, T.; Flaws, D.; Reiter, M.; Lamanna, A.; Haaf, P.; Pemberton, C.; Richards, A.; Chu, K.; Reid, Christopher; Peacock, W.; Jaffe, A.; Florkowski, C.; Deely, J.; Than, M. (2013)Objectives The study objective was to validate a new high-sensitivity troponin I (hs-TnI) assay in a clinical protocol for assessing patients who present to the emergency department with chest pain. Background Protocols ...
Accelerated diagnostic protocol using high-sensitivity cardiac troponin T in acute chest pain patientsMeller, B.; Cullen, L.; Parsonage, W.; Greenslade, J.; Aldous, S.; Reichlin, T.; Wildi, K.; Twerenbold, R.; Jaeger, C.; Hillinger, P.; Haaf, P.; Puelacher, C.; Kern, V.; Rentsch, K.; Stallone, F.; Gimenez, M.; Ballarino, P.; Bassetti, S.; Walukiewicz, A.; Troughton, R.; Pemberton, C.; Richards, M.; Chu, Chuan-Wei; Reid, Christopher; Than, M.; Mueller, C. (2015)Background: We aimed to evaluate the efficacy and safety of using high-sensitivity cardiac troponin T (hs-cTnT) within an accelerated diagnostic protocol (ADP) in patients presenting with symptoms suggestive of acute ...
2-Hour accelerated diagnostic protocol to assess patients with chest pain symptoms using contemporary troponins as the only biomarker: The ADAPT trialThan, M.; Cullen, L.; Aldous, S.; Parsonage, W.; Reid, Christopher; Greenslade, J.; Flaws, D.; Hammett, C.; Beam, D.; Ardagh, M.; Troughton, R.; Brown, A.; George, P.; Florkowski, C.; Kline, J.; Peacock, W.; Maisel, A.; Lim, S.; Lamanna, A.; Richards, A. (2012)Objectives: The purpose of this study was to determine whether a new accelerated diagnostic protocol (ADP) for possible cardiac chest pain could identify low-risk patients suitable for early discharge (with follow-up ...